|
MDMC
SNRY, FTTN, AEMD, AQUS, ALGF, BTDG
Our Stocks to Watch today include Marine Drive Mobile Corp. (OTCBB: MDMC), Solar Energy Initiatives Inc. (OTCBB: SNRY), First Titan Corp. (OTCBB: FTTN), Aethlon Medical Inc. (OTC: AEMD), Aquasil International Inc. (OTCQB: AQUS), Algae Farm (USA) Inc. (OTC: ALGF) and B2 Digital Inc. (OTC: BTDG).
FEATURED COMPANY
MARINE DRIVE MOBILE CORPORATION (OTCBB: MDMC)
Detailed Quote: http://www.otcpicks.com/quotes/MDMC.php
Company Profile: http://bit.ly/IOQW9u
Marine Drive Mobile Corp. engages in the development of transactional mobile commerce applications and services. The company’s technology platform matches merchants and consumers with the right products and services at the right time through electronic coupons. Its principal product includes eTeeoff.com, an e-couponing Website for golf industry merchants to create deals and offer their own electronic coupons. The company was formerly known as Sona Resources, Inc. and changed its name to Marine Drive Mobile Corp. in July 2011. Marine Drive Mobile Corp. was founded in 2007 and is headquartered in San Francisco, California.
MDMC News:
May 2 - Marine Drive Mobile Signs its First JV Agreement with TapIn Solutions, Unleashing an Immediate Sales Channel and New Revenue Stream
Marine Drive Mobile Corp. (OTCBB: MDMC) ("Marine Drive Mobile" or the "Company") announced that the Company has signed a Joint Venture agreement with TapIn Solutions, LLC that will introduce an immediate sales channel to reach golf courses and other businesses for our flagship product eTeeoff.com.
eTeeoff.com is a relatively new online platform targeted to serve the golf industry. With eTeeoff.com advancing to become the leader in offering golf courses the natural ability to offer deals and strategic marketing solutions to their clients, TapIn Solutions paves the road to strategically catapult eTeeoff.com to the next level.
The joint venture agreement with TapIn Solutions is to make our software available to their merchants across the country. This four-year old company, TapIn, is the golf industry's fastest growing online services company specializing in web development and online marketing solutions. Through its various partners, TapIn has access to over 3,400 golf courses and 450 golf product distributors across the country.
As part of the agreement with TapIn we are initially launching with approximately 150 golf courses throughout the U.S., and we are expected to be up and running in June 2012. This is the first phase of this integration, with ultimately integrating into TapIn's entire network.
Colin MacDonald, President and CEO of Marine Drive Mobile stated, "TapIn was one company that we were introduced to at the PGA Merchandise Show in January of this year. Our two companies together, offer such synergies, that we created a win-win venture. We recognized that TapIn would give us a significant edge in procuring a solid merchant base for our flagship product, eteeoff.com and thus rapidly advance our revenue stream timeline."
Reed Thompson, President and CEO of TapIn Solutions, LLC commented, "We are very excited to be working with the eTeeoff.com platform and Marine Drive's technical team. We love their technology; as it introduces an online gateway for our golf merchants to offer substantial deals to their customers. Marine Drive's technology platform opens new doors for our clients and adds a critical link to be competitive in today's golf market. This opportunity basically allows our golf customers to be in the drivers seat, in other words, they will have full control over their marketing needs by using eTeeoff.com's Deal Management System."
ABOUT TAPIN SOLUTIONS, LLC.
TapIn Solutions provides the most comprehensive online, on-demand sales and marketing solutions available exclusively for the Golf Industry. TapIn begins with a truly unique website design, and along with 17 unique modules in its Content Management System (CMS) give their golf customers a distinct advantage over their competition, and this endears TapIn to its customer base. Golf Course operators also look to TapIn for detailed marketing plans, email marketing advice, and overall business & marketing expertise.
SOLAR ENERGY INITIATIVES INCORPORATED (OTCBB: SNRY)
"Up 81.58% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/SNRY.php
Solar Energy Initiatives, Inc. is a diversified provider of solar solutions with three principal operating groups focused on large-scale projects, solar education and distribution of solar products. SNRY Power is a developer and manager of municipal and commercial scale solar projects. The SolarEos Group is dedicated to the education and continuous improvement of solar energy trade professionals. SNRY Solar is a wholesale distributor of branded photovoltaic and thermal (water heating) systems selling via a network of dealers throughout the United States and the Caribbean. Solar Energy Initiatives also owns SolarEnergy.com, one of the most visited solar websites on the internet and a digital property committed to driving consumer traffic, while serving as a platform for awareness of the benefits of solar and a source of business lead generation to SNRY Solar's channel partners. Through its diversified portfolio of solar businesses, Solar Energy Initiatives, Inc. is committed to restoring the nation's economy through a grassroots campaign called "Renew the Nation." Renew the Nation brings together a broad alliance of public and private sector interests focused on workforce development, job creation and economic growth through solar energy.
SNRY News:
May 8 - Solar Energy Initiatives Signs Definitive Agreement to Purchase Internet Digital Marketing Company
Announces Corporate Restructure
Solar Energy Initiatives, Inc. (OTCBB: SNRY), a diversified provider of solar solutions with two principal wholly owned subsidiaries focused on large-scale projects, announced that the company has signed a definitive agreement to purchase certain assets of a company focused in the digital internet marketing space. The asset purchase is scheduled to close no later than July 15, 2012.
Our plan of acquiring a leading media & data solutions provider which is focused on connecting their clients to a targeted audience across multiple sales, marketing and distribution channels gives the company a strong platform on which to launch our new business strategy into the explosive internet digital marketing space. We plan to leverage all digital media options to drive new customers, increase sales, and increase revenue to build shareholder value. The plan is to provide everything a business needs to successfully promote their business on the internet. Future plans include a merger and acquisition strategy to increase client base and company revenues. Future acquisitions are directed toward businesses involved in internet technology, enabled business processes, data, Internet marketing or e-commerce, and service businesses including web enabled software platforms.
"Solar Energy Initiatives has been working to recapitalize the company and seek out new growth opportunities in order to maximize shareholder value. The decision was made due to the reduction in value of its current solar business.
"The Company has been seeking an acquisition candidate in order improve the financial condition of the company to protect the interests of the shareholders," stated David Fann, Chief Executive Officer of Solar Energy Initiatives.
Solar Energy Initiatives Inc. (the "Company") recently filed a Certificate of Correction to its Certificate of Amendment to the Certificate of Incorporation (the "Certificate") to effect a reverse stock split of all outstanding shares of common stock at a ratio of 1 for 100 (the "Reverse Stock Split"). Fractional shares outstanding after the Reverse Stock Split will be rounded up to the next highest number of full shares. The Certificate was approved by the Board of Directors and shareholders holding a majority of the issued and outstanding shares of common stock.
FIRST TITAN CORPORATION (OTCBB: FTTN)
"Up 28.57% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/FTTN.php
First Titan Corp., through its wholly owned subsidiary, First Titan Energy, LLC, is committed to the exploration and development of oil and natural gas resources around the globe. The company continually seeks to partner with energy developers that are pursuing innovative new methods of oil and gas extraction, including the development of new technologies, cleaner methods and unconventional resources.
FTTN News:
Promising early production from a new horizontal well in Logan County, Okla., has First Titan Corp. (OTCBB: FTTN) increasingly excited about the potential for its own assets in the region.
Last month, one of FTTN’s competitors, Osage Exploration and Development, Inc. (OTCBB: OEDV) announced that the 72-hour Initial Production rate on its Wolf 1-29 horizontal well in Kay County, Okla., averaged over 1,185 BOE/D. The total production was composed of approximately 85 percent oil and 15 percent high BTU natural gas, and the average production during the first full 30 days on the Wolf was over 876 BOE/D.
The well was drilled to a vertical depth of 5,816 feet with a lateral bore length of 4,104 feet and was treated with a multi-stage hydraulic fracking job.
Osage’s highly encouraging preliminary results have increased FTTN’s expectations for its own horizontal well project in Logan County. Last month, the company acquired a working interest in a similar horizontal well known as Breaux #2 that is drilled to a vertical depth of 5,456 feet with a lateral bore length of 2,704 and which is being prepared for a completion with a multi-stage hydraulic fracking job.
The well sponsor, Bedford Energy, Inc., has had the Breaux #2 well engineered. The Petroleum Engineers reserve report based on wells close by shows proven reserves of 160,000 bbls of oil and 1.5 million mcf of natural gas, estimating potential production at more than $14 million worth of resources.
Bedford Energy estimates the well completion at between 30 and 60 days from funding, potentially providing a quick return on investment in the project.
First Titan Corp. is aggressively pursuing promising new oil and gas opportunities throughout the Southern U.S. Breaux #2 is FTTN’s fourth working interest in prospective domestic wells. The company has already acquired working interests in three new wells in Texas, Louisiana and Alabama this year.
AETHLON MEDICAL INCORPORATED (OTCBB: AEMD)
"Up 6.19% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/AEMD.php
The Aethlon Medical mission is to create innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer; HER2osome™ to target HER2+ breast cancer, and a medical device being developed under a contract with DARPA that would reduce the incidence of sepsis in combat-injured soldiers and civilians.
AEMD News:
May 8 - Aethlon Medical Reports Undetectable Hepatitis C Virus (HCV) in Genotype 1, Genotype 3, and Genotype 5 Patients Treated with Hemopurifier® Therapy
Aethlon Medical, Inc. (OTC: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, reported today that the presence of Hepatitis C virus (HCV) is currently undetectable in all infected patients that have been treated with the Aethlon Hemopurifier® in combination with peginterferon+ribavirin (PR) drug therapy and monitored for at least ninety days.
In a study conducted at the Medanta Medicity Institute (Medicity), HCV-infected individuals were enrolled to receive up to three, six-hour Hemopurifier® treatments during the first three days of PR drug therapy. The Medicity is a $360 million multi-specialty medical institute established to be a premier center for medical tourism in India. The Aethlon Hemopurifier® is a first-in-class medical device that selectively targets the rapid clearance of HCV from the entire circulatory system to improve benefit, dose, duration and tolerability of drug therapies.
In the Medicity study, Aethlon reported that Hemopurifier® therapy has been well tolerated and without device-related adverse events in nine treated patients. Of these nine patients, six patients were infected with HCV genotype-1; two patients were infected with HCV genotype-3; and one patient was infected with HCV genotype-5. Of the nine reported patients, seven have been monitored for more than ninety days. All seven currently maintain undetectable viral load, including three patients who have been monitored for 48-weeks. Two patients initiated Hemopurifier® therapy on April 18th and April 30th, and therefore have not yet been monitored for extended viral load suppression.
The Immediate Impact of Hemopurifier® Therapy
In addition to demonstrating safety and early efficacy against multiple HCV genotypes, a clinical objective of the Medicity study was to evaluate whether the Hemopurifier® could accelerate HCV eradication to levels associated with treated patients who achieve the highest rate of viral cure, including individuals that previously failed or relapsed PR drug regimens. In the study, Aethlon observed that viral load depletion during the Hemopurifier® + PR drug therapy phase was greatest in hard-to-treat genotype-1 patients with high viral load. In one treated patient, baseline HCV RNA dropped from 5,800,000 IU/ml to 1,840 IU/ml when measured after the third day of Hemopurifier® + PR therapy, representing a 3.49 log or 99.96% reduction of viral load. In another patient, baseline HCV RNA dropped from 8,760,000 IU/ml to 4,665 IU/ml when measured on day-3, representing a 3.27 log or 99.96% reduction. By contrast, a moderate viral load Hemopurifier® patient with baseline HCV RNA of 1,340,000 IU/ml dropped to 54,900 IU/ml when measured on day-3, representing a 1.38 log or 95.9% reduction.
As a point of reference, the landmark IDEAL Study of 3,070 HCV genotype-1 patients documented that less than 5% of treated patients will achieve a 2-log or greater reduction of viral load when measured 7-days after the start of PR drug therapy. While the IDEAL study did not report day-3 viral load, a 2-log+ reduction at day-7 is a rare occurrence defined as an immediate virologic response (IVR). The IDEAL study confirms the viral cure or sustained virologic response rate of IVR patients to be greater than 90%. Based on Medicity treatment outcomes, Hemopurifier® therapy had a significant impact in accelerating HCV eradication in high viral load patients.
Capacity of the Hemopurifier® to Capture HCV During Treatment
As the result of discussions with reviewers at the Center for Devices and Radiological Health (the FDA branch responsible for approving medical devices in the US), Aethlon recently expanded the Medicity protocol to establish a data point that would quantify the amount of HCV captured within the Hemopurifier® during a single treatment. In one analyzed cartridge, researchers recovered and measured that approximately 300 billion (300,000,000,000) copies of HCV had been captured within the Hemopurifier® during a single six-hour treatment at the Medicity. Beyond the impact of inhibiting progeny virus replication, the viral capture data point defines the contribution Hemopurifier® therapy can provide to current and future antiviral drug treatment regimens. Aethlon considers this data point to be unprecedented as the previous ability to measure the benefit of HCV therapies has primarily been limited to measuring changes in the amount of virus that can be detected in circulation.
Next Steps
As a result of Hemopurifier® + PR therapy outcomes, Aethlon has requested permission from the Medicity internal review board (IRB) to begin offering Hemopurifier® therapy to HCV-infected individuals that reside outside of India. The Company has also requested IRB permission to expand the treatment protocol to allow for up to seven Hemopurifier® treatments to be administered during the first week of PR drug therapy. Based on previous three-treatment protocol outcomes, Aethlon anticipates an expanded Hemopurifier® dosing schedule could establish new milestones for early undetectable viral load achievement. The Company also disclosed it will resubmit an investigational device exemption (IDE) which incorporates the Medicity data as part of its effort to gain FDA approval to initiate clinical programs in the U.S.
It is estimated that approximately 4 million Americans and 170 million people worldwide are infected with HCV, which leads to chronic liver disease or cirrhosis, and is the leading cause of liver transplant in the U.S. To date, almost 100 Hemopurifier® treatments have been administered in human studies. Previously, studies of the Hemopurifier® have been conducted at the Apollo, Fortis, and Sigma New Life hospitals in India. These studies demonstrated that Hemopurifier® therapy could safely reduce viral load in both HIV and HCV-infected dialysis patients without the administration of antiviral drug therapies. The Medicity study represents the first Hemopurifier® study in non-dialysis patients. In vitro studies have further validated the ability of the Hemopurifier® to capture a broad-spectrum of viral pathogens classified as bioterror or pandemic threats.
AQUASIL INTERNATIONAL INCORPORATED (OTC: AQUS)
"Up 52.17% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/AQUS.php
Aquasil International Inc., a development stage company, through its subsidiary, AquaSil, Inc., engages in the distribution of various water and soft drink products in the United States. It primarily distributes mineral water produced by Khasid ICT under the Mineral Silver Water brand name. The company was founded in 2010 and is based in New York, New York.
AQUS News:
No recent news for Aquasil International, Inc. (OTCQB: AQUS).
ALGAE FARM (USA) INCORPORATED (OTC: ALGF)
"Up 66.67% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/ALGF.php
Algae Farm (USA), Inc., a development stage company, engages in the research and development of alternative and renewable energy. It primarily focuses on algae oil production. The company was formerly known as Russell Industries, Inc. and changed its name to Algae Farm (USA), Inc. on January 6, 2011. Algae Farm (USA), Inc. was founded in 1997 and is based in The Woodlands, Texas.
ALGF News:
No recent news for Algae Farm (USA), Inc. (OTC: ALGF).
B2DIGITAL INCORPORATED (OTC: BTDG)
"Up 200.00% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/BTDG.php
B2 Digital is dedicated to seeking acquisitions, mergers and joint ventures with a scope of business opportunities including the resource sector. With a merger of this type B2 Digital will become a part of one great organization, SSM Media Ventures, Inc. and RHN.
BTDG News:
No recent news for B2 Digital, Inc. (OTC: BTDG).
|
